Factors influencing women’s preferences for treatment of their fibroid
Research type
Research Study
Full title
What factors influence women’s preference for treatment of their uterine fibroids? A mixed methods study.
IRAS ID
179542
Contact name
Stephen Quinn
Contact email
Sponsor organisation
Imperial College Healthcare NHS Trust
Duration of Study in the UK
0 years, 3 months, 14 days
Research summary
Fibroids are benign tumours affecting the uterus (womb). They are thought to affect between 25 and 50% of all women. Traditionally the usual treatment for fibroids causing symptoms was surgical, involving either removal of the fibroids (myomectomy) or hysterectomy (removal of the womb). There are now a greater number of treatment options for women with uterine fibroids including less invasive options such as uterine artery embolization (UAE) and Magnetic Resonance guided Focused Ultrasound (MRgFUS). We wish to understand more about how fibroids affect women and their treatment choices.
The hypothesis is that treatment choices are driven by a number of factors which include symptom experience, health beliefs and mental state including depression and anxiety. These factors may influence the choice of treatment modality even when that modality might not be the indicated based on the clinical evidence for effectiveness and safety.
REC name
London - Surrey Research Ethics Committee
REC reference
16/LO/0850
Date of REC Opinion
25 May 2016
REC opinion
Favourable Opinion